Patents by Inventor Csaba WÉBER

Csaba WÉBER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230097678
    Abstract: A compound of formula (I): wherein Z, Y1, Y2, R1 to R7 are as defined in the description, its optical isomers, and addition salts thereof with a pharmaceutically acceptable base. Medicaments.
    Type: Application
    Filed: February 26, 2021
    Publication date: March 30, 2023
    Inventors: Csaba WÉBER, Klaus SEEDORF, Didier DURAND, Márió GYURIS, Árpád KISS, Zoltán MADARÁSZ, Mark MOLNÁR, Miklós NYERGES, Monika RUDASOVÁ, Attila SÁPI, Sylvie BERGER, Valérie DUVIVIER, Virginie MARTINY, Isabelle THERET, Cédric VINSON
  • Patent number: 11332472
    Abstract: Compounds of formula (I): wherein R1, R2, R3, B, W, Z, m and n are as defined in the description.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: May 17, 2022
    Assignees: LES LABORATOIRES SERVIER, VERNALIS (R&D) LTD
    Inventors: András Kotschy, Csaba Wéber, Attila Vasas, Árpád Kiss, Balázs Molnár, Ágnes Strofek, Vilibald Kun, James Brooke Murray, Alba Macias, Elodie Lewkowicz, Maïa Chanrion, Lisa Ivanschitz, Olivier Geneste
  • Publication number: 20210355106
    Abstract: wherein R1, R2, R3, R4, R5, n and Q are as defined in the description.
    Type: Application
    Filed: October 18, 2019
    Publication date: November 18, 2021
    Inventors: Csaba WÉBER, András KOTSCHY, Attila VASAS, Árpád KISS, Balázs MOLNÁR, Andrea FIUMANA, Alba MACIAS, James Brooke MURRAY, Didier DEMARLES, Lisa IVANSCHITZ, Olivier GENESTE, Kristóf HEGEDÜS, Péter SPRÁNITZ, Tibor SOÓS
  • Publication number: 20210221785
    Abstract: Compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, J and n are as defined in the description.
    Type: Application
    Filed: July 4, 2019
    Publication date: July 22, 2021
    Inventors: Csaba WÉBER, András KOTSCHY, Attila VASAS, Árpád KISS, Balázs MOLNÁR, Alba MACIAS, Andrea FIUMANA, Nicolas DAVIES, James Brooke MURRAY, Emilie SELLIER, Didier DEMARLES, Lisa IVANSCHITZ, Olivier GENESTE
  • Patent number: 11046681
    Abstract: Compounds of formula (I): wherein R1, R2, R3, n and W are as defined in the description. Medicinal products containing the same which are useful in treating conditions requiring pro-apoptotic and/or anti-proliferative agents.
    Type: Grant
    Filed: June 9, 2017
    Date of Patent: June 29, 2021
    Assignees: LES LABORATOIRES SERVIER, VERNALIS (R&D) LTD
    Inventors: András Kotschy, Csaba Wéber, Attila Vasas, Balázs Molnár, Árpád Kiss, Alba Macias, James Brooke Murray, Elodie Lewkowicz, Olivier Geneste, Maïa Chanrion, Didier Demarles
  • Publication number: 20200407363
    Abstract: Compounds of formula (I): wherein R1, R2, R3, B, W, Z, m and n are as defined in the description.
    Type: Application
    Filed: November 28, 2018
    Publication date: December 31, 2020
    Inventors: András KOTSCHY, Csaba WÉBER, Attila VASAS, Árpád KISS, Balázs MOLNÁR, Ágnes STROFEK, Vilibald KUN, James Brooke MURRAY, Alba MACIAS, Elodie LEWKOWICZ, Maïa CHANRION, Lisa IVANSCHITZ, Olivier GENESTE
  • Patent number: 10654849
    Abstract: Compounds of formula (I): wherein R1, R2, J, K, L, n and W are as defined in the description. Medicinal products containing the same which are useful in treating conditions requiring pro-apoptotic and/or anti-proliferative agents.
    Type: Grant
    Filed: June 9, 2017
    Date of Patent: May 19, 2020
    Assignees: LES LABORATOIRES SERVIER, VERNALIS (R&D) LTD
    Inventors: András Kotschy, Csaba Wéber, Attila Vasas, Balázs Molnár, árpád Kiss, Alba Macias, James Brooke Murray, Elodie Lewkowicz, Olivier Geneste, Mäia Chanrion, Didier Demarles, Lisa Ivanschitz
  • Publication number: 20190144449
    Abstract: Compounds of formula (I): wherein R1, R2, J, K, L, n and W are as defined in the description. Medicinal products containing the same which are useful in treating conditions requiring pro-apoptotic and/or anti-proliferative agents.
    Type: Application
    Filed: June 9, 2017
    Publication date: May 16, 2019
    Inventors: András KOTSCHY, Csaba WÉBER, Attila VASAS, Balázs MOLNÁR, Árpád KISS, Alba MACIAS, James Brooke MURRAY, Elodie LEWKOWICZ, Olivier GENESTE, Maïa CHANRION, Didier DEMARLES, Lisa IVANSCHITZ
  • Publication number: 20190144448
    Abstract: Compounds of formula (I): wherein R1, R2, R3, n and W are as defined in the description. Medicinal products containing the same which are useful in treating conditions requiring pro-apoptotic and/or anti-proliferative agents.
    Type: Application
    Filed: June 9, 2017
    Publication date: May 16, 2019
    Inventors: András KOTSCHY, Csaba WÉBER, Attila VASAS, Balázs MOLNÁR, Árpád KISS, Alba MACIAS, James Brooke MURRAY, Elodie LEWKOWICZ, Olivier GENESTE, Maïa CHANRION, Didier DEMARLES
  • Publication number: 20180273528
    Abstract: Compounds of formula (I): wherein R1, R2, R3, R4, and R5 are as defined in the description. Medicinal products containing the same which are useful in treating cancer, neurodegenerative disorders and metabolic disorders.
    Type: Application
    Filed: September 30, 2016
    Publication date: September 27, 2018
    Inventors: Balázs BÁLINT, András KOTSCHY, Melinda SIPOS, Csaba WÉBER, Nicolas FOLOPPE, David WALMSLEY, Michael BURBRIDGE, Francisco Humberto CRUZALEGUI
  • Patent number: 8063220
    Abstract: The present invention relates to new mGluR1 and mGluR5 receptor subtype preferring ligands of formula (I) and/or salts and/or hydrates and/or solvates and/or polymorphs thereof. The invention also relates to processes and intermediates for their preparation, to pharmaceutical compositions containing these compounds and to their use in treatment and/or prevention of conditions which require modulation of mGluR1 and mGluR5 receptors.
    Type: Grant
    Filed: June 23, 2008
    Date of Patent: November 22, 2011
    Assignee: Richter Gedeon Nyrt.
    Inventors: Janos Galambos, Gyorgy Keseru, Krisztina Gal, Monika Vastag, Amrita Agnes Bobok, Csaba Weber, Ibolya Prauda, Gabor Wagner
  • Publication number: 20090270371
    Abstract: Compounds of formula (I): and/or enantiomers and/or racemates and/or diastereomers and/or pharmaceutically acceptable salts thereof formed with acids or bases, to the process for their preparation, to the intermediates of the preparation process, to the pharmaceutical formulations containing these compounds and to their use in the prevention and/or treatment of mGluR5 receptor-mediated disorders.
    Type: Application
    Filed: December 19, 2006
    Publication date: October 29, 2009
    Inventors: Gyorgy Keseru, Csaba Weber, Attila Bielik, Amrita Agnes Bobok, Krisztina Gal, Marta Meszlenyine Sipos, Laszlo Molnar, Monika Vastag
  • Publication number: 20090042934
    Abstract: The present invention relates to new mGluR1 and mGluR5 receptor subtype preferring ligands of formula (I) and/or salts and/or hydrates and/or solvates and/or polymorphs thereof. The invention also relates to processes and intermediates for their preparation, to pharmaceutical compositions containing these compounds and to their use in treatment and/or prevention of conditions which require modulation of mGluR1 and mGluR5 receptors.
    Type: Application
    Filed: June 23, 2008
    Publication date: February 12, 2009
    Inventors: Janos Galambos, Gyorgy Keseru, Krisztina Gal, Monika Vastag, Amrita Agnes Bobok, Csaba Weber, Ibolya Prauda, Gabor Wagner